aDivision of Experimental Medicine, Department of Medicine, McGill University
bCardiovascular Health Across the Lifespan (CHAL) Program, Research Institute of the McGill University Health Centre
cDivision of Internal Medicine, Department of Medicine, McGill University Health Center
dCentre for Outcomes Research and Evaluation (CORE), Research Institute of the McGill University Health Centre, McGill University, Montreal, Quebec, Canada
eBiomedical Engineering Unit, First Department of Cardiology, Medical School, Hippokration Hospital, National and Kapodistrian University of Athens, Greece
fFaculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta
gMetabolism, Obesity and Nutrition Laboratory, PERFORM Centre
hDepartment of Health, Kinesiology, and Applied Physiology, Concordia University, Montreal, Quebec, Canada
Correspondence to Stella S. Daskalopoulou, MD, MSc, DIC, PhD, Associate Professor (tenured) in Medicine, FRQ-S Chercheur-Boursier Clinicien -- Senior, Director, Vascular Health Unit, Division of Internal Medicine, Department of Medicine, McGill University Health Centre, 1001 Decarie Blvd, EM1.2230, Montreal, QC H4A 3J1, Canada. Tel: +1 514 934 1934 x76251; fax: +1 514 934 8564; e-mail: [email protected]
Abbreviations: AHA, American Heart Association; cfPWV, carotid–femoral pulse wave velocity; CI, confidence interval; CVD, cardiovascular disease; IQR, interquartile range; MUHC, McGill University Health Centre; SD, standard deviation; T2DM, type 2 diabetes mellitus
Received 6 July, 2020
Revised 10 August, 2020
Accepted 30 August, 2020
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (http://www.jhypertension.com).
